Vertex (VRTX) Begins Rolling NDA Filing for Acute Pain Drug [Yahoo! Finance]
Vertex Pharmaceuticals Incorporated (VRTX)
Last vertex pharmaceuticals incorporated earnings: 4/29 04:01 pm
Check Earnings Report
US:NASDAQ Investor Relations:
investors.vrtx.com
Company Research
Source: Yahoo! Finance
The company has already initiated the rolling submission process and is on track to complete the NDA submission in the second quarter of 2024. Suzetrigine is an investigational orally administered selective NaV1.8 pain signal inhibitor. The rolling NDA submission is supported by encouraging results from the company's phase III program for suzetrigine in acute pain management. In January 2024, Vertex reported that it had met the primary endpoints in three phase III studies evaluating suzetrigine to treat moderate-to-severe acute pain. The late-stage studies included two pivotal phase III acute pain studies, one following bunionectomy surgery and the other following abdominoplasty surgery, and a 14-day single-arm phase III study across a broad range of other surgical and non-surgical acute pain conditions. Data from the studies showed that treatment with suzetrigine led to a significant reduction in pain intensity across a range of pain conditions, both surgical and non-surgical,
Show less
Read more
Impact Snapshot
Event Time:
VRTX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
VRTX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
VRTX alerts
High impacting Vertex Pharmaceuticals Incorporated news events
Weekly update
A roundup of the hottest topics
VRTX
News
- Vertex Pharmaceuticals Incorporated (VRTX) Is a Trending Stock: Facts to Know Before Betting on It [Yahoo! Finance]Yahoo! Finance
- American Kidney Fund Encourages People to Be APOL1 Aware with First Annual APOL1-Mediated Kidney Disease (AMKD) Awareness Day [Yahoo! Finance]Yahoo! Finance
- Vertex Pharmaceuticals (VRTX) Earnings Expected to Grow: Should You Buy? [Yahoo! Finance]Yahoo! Finance
- 2 Top Growth Stocks to Buy Right Now and Hold Forever [Yahoo! Finance]Yahoo! Finance
- Pioneer Institute study finds IRA discourages non-opioid drug innovation [Yahoo! Finance]Yahoo! Finance
VRTX
Earnings
- 2/5/24 - Beat
VRTX
Sec Filings
- 5/2/24 - Form 144
- 4/17/24 - Form 4
- 4/16/24 - Form PX14A6G
- VRTX's page on the SEC website